The FDA's top regulator of medicines has resigned after being accused of using his regulatory authority to harm a former ...

Yesterday, STAT’s Lizzy Lawrence and Adam Feuerstein scored another exclusive: The FDA’s top drug regulator has been placed ...

In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now ...

Caribou Biosciences said its off-the-shelf CAR-T therapy induced complete and durable remissions in patients with advanced ...

The Americas is the only region of the world to have stopped endemic transmission of measles. But its victory is on the verge ...

George Tidmarsh denied wrongdoing at the FDA and accused senior FDA officials — including CBER chief Vinay Prasad — of wrongdoing ...

George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory ...

Wes Edwards, chief financial officer of primary and urgent care chain Med First, pulls no punches when it comes to money and health care. “We’re a for-profit entity that believes that the more margin ...

When Big Pharma ties its corporate social responsibility initiatives to patients' needs, too often it veers into theater.

WASHINGTON — President Trump said Sunday that he planned to help the creator of the satirical comic strip “Dilbert” get access to a prostate cancer drug.

Dozens of scientists are considering leaving the Center for Biologics Evaluation and Research, where Prasad serves as ...

Medicare on Friday followed through with its earlier proposal to reduce payment for surgeries, outpatient procedures, and other services it believes can be done more efficiently starting in 2026.